Status:
UNKNOWN
Alternating DBS for Stepping Control in Parkinson's Disease
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
University College, London
Conditions:
Parkinson Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Parkinson's disease (PD) is a disabling, progressive condition characterised by severe problems with movement for which medical treatment in the longer term can be unsatisfactory. Deep brain stimulati...
Eligibility Criteria
Inclusion
- PD patients with bilateral subthalamic nucleus DBS electrodes and stimulators implanted for at least 6 months
- Able to give consent.
Exclusion
- Lack of capacity to consent
- Cognitive impairment/lack of capacity to perform experimental task. The investigators will additionally conduct a short (10 min) quantitative assessment of cognitive function using a validated test (MMSE). Patients with a score \< 20 will be excluded from the study.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04047498
Start Date
May 1 2019
End Date
November 1 2020
Last Update
August 6 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London Hospitals NHS Trust
London, United Kingdom, WC1N 3BG
2
University of Oxford
Oxford, United Kingdom, OX3 9DU